| 000 | 01838 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513094104.0 | ||
| 264 | 0 | _c19961016 | |
| 008 | 199610s 0 0 eng d | ||
| 022 | _a1053-2498 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSmart, F W | |
| 245 | 0 | 0 |
_aRisk factors for early, cumulative, and fatal infections after heart transplantation: a multiinstitutional study. _h[electronic resource] |
| 260 |
_bThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation _cApr 1996 |
||
| 300 |
_a329-41 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aActuarial Analysis |
| 650 | 0 | 4 | _aBlack or African American |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 |
_aBacterial Infections _xepidemiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHeart Transplantation |
| 650 | 0 | 4 | _aHeart-Assist Devices |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMuromonab-CD3 _xtherapeutic use |
| 650 | 0 | 4 |
_aMycoses _xepidemiology |
| 650 | 0 | 4 |
_aPostoperative Complications _xepidemiology |
| 650 | 0 | 4 |
_aProtozoan Infections _xepidemiology |
| 650 | 0 | 4 | _aRespiration, Artificial |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSex Factors |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTissue Donors |
| 650 | 0 | 4 |
_aVirus Diseases _xepidemiology |
| 700 | 1 | _aNaftel, D C | |
| 700 | 1 | _aCostanzo, M R | |
| 700 | 1 | _aLevine, T B | |
| 700 | 1 | _aPelletier, G B | |
| 700 | 1 | _aYancy, C W | |
| 700 | 1 | _aHobbs, R E | |
| 700 | 1 | _aKirklin, J K | |
| 700 | 1 | _aBourge, R C | |
| 773 | 0 |
_tThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation _gvol. 15 _gno. 4 _gp. 329-41 |
|
| 999 |
_c8729666 _d8729666 |
||